Skip to main content

Author: Customer Service

Ellomay Capital Consummates the Sale of its Indirect Holdings in Dorad Energy Ltd.

Final Purchase Price is NIS 559.8 Million Tel-Aviv, Israel, May 10, 2026 (GLOBE NEWSWIRE) —  Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, today announced the consummation of the sale of its holdings (50%) in Ellomay Luzon Energy Infrastructures Ltd. (“Ellomay Luzon Energy”) to the Amos Luzon Development and Energy Group Ltd. (the “Luzon Group”). Ellomay Luzon Energy’s main asset is its holding of 33.75% of Dorad Energy Ltd. (“Dorad”). The consideration was based on a Dorad valuation of NIS 4.4 billion, i.e. a valuation of NIS 742.5 million for the Company’s indirect holdings in Dorad, net of 50% of Ellomay Luzon Energy’s net debt (outstanding bank loans minus cash and cash equivalents)...

Continue reading

MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results

MoonLake conducted a positive final pre-BLA (Biologics License Application) meeting with the U.S. Food and Drug Administration (FDA), where MoonLake and the FDA aligned on submission plans and the label strategy for sonelokimab (SLK) in hidradenitis suppurativa (HS) This included the acceptability of MIRA trial data to establish substantial evidence of effectiveness (SEE), full inclusion of the VELA-TEEN trial data for a label including patients aged 12 years and above, and the strategy for inclusion of safety data across the MIRA and VELA trials – this aligns with the scenario presented at the Investor Day on February 23, 2026 The proposed label in HS is therefore expected to include the MIRA trial’s ~43% HiSCR75 response and the ~29 percentage point delta-to-placebo at week 12, which are the highest values observed across any adequate...

Continue reading

Sigenergy Demonstrates Full-Scale Energy Commitment at SEC 2026 with Expanded Energy Storage Solutions and Local Service Strength

SYDNEY, May 09, 2026 (GLOBE NEWSWIRE) — As Australia accelerates its transition to cleaner, smarter energy, Sigenergy made a powerful statement at Smart Energy Conference & Exhibition 2026, presenting one of the industry’s most comprehensive integrated energy portfolios at the International Convention Centre, Sydney. Over two days at Australia’s leading renewable energy event, Sigenergy engaged residential, commercial, and utility stakeholders across its expanding smart energy ecosystem, combining proven technology with a growing local service capability tailored to the Australian market. Visitors explored Sigenergy’s residential lineup, including a preview of SigenStor Neo, the company’s next-generation all-in-one residential energy system that integrates the inverter, battery, PCS, EMS, and gateway into a single unit.A...

Continue reading

Grupo Aeroportuario del Pacifico Announces Initiation of the Process to Establish a FIBRA

GUADALAJARA, Mexico, May 09, 2026 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (the “Company” or “GAP”) announces that it has initiated the process for the potential establishment of an Irrevocable Trust for the Issuance of Energy and Infrastructure Investment Trust Certificates (“FIBRA GAP”), with the objective of subscribing a minority equity interest in the 12 Mexican airport concessionaires operated by GAP. Through the initial issuance of FIBRA GAP, each of the 12 airports intends to obtain funds to complement the execution of the Master Development Program for the 2026–2029 period, which contemplates investments of approximately Ps. 40.0 billion. The Master Development Program will generate significant growth in airport infrastructure, including an approximate increase of 60% in...

Continue reading

Elegance Moves the World: LEPAS L6 PHEV Global Journey of Elegant Driving Wraps Up

WUHU, China, May 08, 2026 (GLOBE NEWSWIRE) — During the 2026 International Business Summit, Chery Group’s LEPAS L6 PHEV Global Journey of Elegant Driving successfully completed its comprehensive test drive across China. As a key validation stage within LEPAS’s three-step strategy—“debut, validation, and co-creation”—the journey began at Auto China 2026, regrouped in Wuxi, and concluded at the LEPAS Global Partner Conference in Wuhu. Covering diverse road conditions and real-world scenarios, it showcased the model’s overall strength while reinforcing the brand vision of “Elegance Moves the World.” Throughout the journey, participants explored how a globally oriented NEV brand can redefine mobility aesthetics through elegant technology. The first stop, Wuxi, provided a setting where traditional Chinese elegance meets European...

Continue reading

iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

May 8, 2026 WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it has priced a private placement with accredited investors for aggregate gross proceeds of approximately $2.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company. In connection with the offering, the Company will issue 488,281 shares of common stock (the “Shares”) at a purchase price of $5.12 per Share. In lieu of Shares that would otherwise result in a purchaser’s beneficial ownership exceeding 4.99% of the outstanding common stock, certain purchasers may elect to receive pre-funded warrants...

Continue reading

Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study

Melbourne, Australia, May 08, 2026 (GLOBE NEWSWIRE) — HIGHLIGHTSAmplia and ANZGOG enter into agreement to conduct a clinical study in ovarian cancer evaluating narmafotinib in combination with standard-of-care chemotherapy Ovarian cancer represents a major target for FAK inhibition therapy based on typically higher levels of FAK expression and fibrous nature of tumour The study to enrol patients with high-grade serous ovarian cancer (HGSOC) who have not responded to platinum-based chemotherapy prior to surgery Study focus is safety and exploring potential to improve post-surgical outcomes; biomarker collection will further characterize mechanism of action of narmafotinib{{DATELINECITY_DATE_GLOBENEWSWIRE_BUG}Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia” or the “Company”), and the Australia New Zealand Gynaecological...

Continue reading

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the LD Micro Invitational XVI Conference being held at the Luxe Sunset Boulevard hotel in Los Angeles, CA.   Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day.   LD Micro Invitational XVI Conference Details: Date: Monday, May 18, 2026 Company Presentation: 10:30 am PT Location: Luxe Sunset Boulevard Hotel, Los Angeles, CA Webcast:   Click for Link For more information or to attend the conference, click here. About electroCore, Inc.electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic...

Continue reading

Lumentum Holdings Inc. to Join the Nasdaq-100 Index® Beginning May 18, 2026

NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced that Lumentum Holdings Inc. (Nasdaq: LITE) will become a component of the Nasdaq-100 Index® replacing CoStar Group, Inc. (Nasdaq: CSGP) prior to market open on Monday, May 18, 2026. For additional information, including notifications on changes to any Nasdaq Indexes, please go to https://indexes.nasdaq.com/ About Nasdaq Global Indexes Nasdaq Global Indexes is one of the world’s leading index providers, offering a comprehensive suite of rules-based benchmarks and indexes. The Nasdaq-100 Index® — which measures the performance of 100 of the largest Nasdaq-listed non-financial companies — is tracked by more than 200 investment products with over $600 billion in assets under management globally. Nasdaq Global Indexes publishes and maintains more than...

Continue reading

Tenaris to Acquire Artrom Steel Tubes S.A. seamless pipe manufacturing plant in Romania

LUXEMBOURG, May 08, 2026 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS; EXM Italy: TEN) announced today that it has entered into a definitive agreement to acquire from GLGH Steel, LLC, a U.S.-based company, 100% of the share capital of Artrom Steel Tubes S.A., for an aggregate purchase price of EUR 86 million, on a cash-free and debt-free basis, including a normalized level of working capital. The transaction is subject to customary regulatory conditions, including clearance from the European Union competition authorities and Romanian government approvals. Closing is expected to occur during the fourth quarter of 2026. Artrom Steel Tubes S.A. is a Romanian manufacturer of steel and seamless steel pipes, with annual steelmaking capacity of approximately 450,000 metric tons at its facility in Reșița, and seamless pipe rolling...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.